SCHEMBL6583786

SCHEMBL6583786

COc1ccccc1CN(C)C([NH])=O

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
CRHBP P24387 1/20 0.62
CRHR2 Q13324 1/20 0.62
GAA P10253 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
BCHE P06276 7/20 0.53
ACHE P22303 7/20 0.53
CHRM2 P08172 2/20 0.53
CHRM1 P11229 1/20 0.53
HPGD P15428 1/20 0.52
NPC1 O15118 1/20 0.51
TACR1 P25103 1/20 0.48
ALDH1A1 P00352 1/20 0.47
MTNR1A P48039 1/20 0.46
MTNR1B P49286 1/20 0.46
AOC3 Q16853 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6583793 0.83 MEN1 (0.62) MEN1KMT2ACRHBPCRHR2GAA
SCHEMBL14540454 0.82 MEN1 (0.74) MEN1KMT2ACRHBPCRHR2GAA
SCHEMBL17882308 0.77 RIPK1 (0.66) MEN1KMT2ACRHBPCRHR2GAA
SCHEMBL735118 0.76 SLC6A4 (0.68) MEN1KMT2ACRHBPCRHR2CHRM2
SCHEMBL415222 0.76 ACHE (0.63) MEN1KMT2ACRHBPCRHR2GAA
SCHEMBL417439 0.76 ACHE (0.63) MEN1KMT2ACRHBPCRHR2GAA
SCHEMBL2974690 0.76 MEN1 (0.66) MEN1KMT2ACRHBPCRHR2GAA
SCHEMBL11329375 0.76 ACHE (0.55) MEN1KMT2ACRHBPCRHR2GAA
SCHEMBL4686006 0.75 GAA (0.55) MEN1KMT2AGAAHPGDNPC1
SCHEMBL21306338 0.75 MEN1 (0.56) MEN1KMT2ACRHBPCRHR2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0865430-B1 3-(4-SUBST.-PIPERIDINYL-1)-1-(3,4-DICHLOROPHENYL)PROPYL CARBAMATES AND UREAS AND DERIVATIVES AS NOVEL NEUROKININ ANTAGONISTS ASTRAZENECA AB (SE) 2004-03-03 EP claimed
EP-0865430-A1 3-(4-SUBST.-PIPERIDINYL-1)-1-(3,4-DICHLOROPHENYL)PROPYL CARBAMATES AND UREAS AND DERIVATIVES AS NOVEL NEUROKININ ANTAGONISTS AstraZeneca AB (SE) 1998-09-23 EP claimed
WO-1997019060-A1 3-(4-SUBST.-PIPERIDINYL-1)-1-(3,4-DICHLOROPHENYL)PROPYL CARBAMATES AND UREAS AND DERIVATIVES AS NOVEL NEUROKININ ANTAGONISTS ZENECA LIMITED (GB) 1997-05-29 WO claimed
EP-0865430-B1 3-(4-SUBST.-PIPERIDINYL-1)-1-(3,4-DICHLOROPHENYL)PROPYL CARBAMATES AND UREAS AND DERIVATIVES AS NOVEL NEUROKININ ANTAGONISTS ASTRAZENECA AB (SE) 2004-03-03 EP disclosed
US-6090824-A Therapeutic neurokinin receptor antagonist compounds ZENECA LIMITED (GB) 2000-07-18 US disclosed
EP-0865430-A1 3-(4-SUBST.-PIPERIDINYL-1)-1-(3,4-DICHLOROPHENYL)PROPYL CARBAMATES AND UREAS AND DERIVATIVES AS NOVEL NEUROKININ ANTAGONISTS AstraZeneca AB (SE) 1998-09-23 EP disclosed
WO-1997019060-A1 3-(4-SUBST.-PIPERIDINYL-1)-1-(3,4-DICHLOROPHENYL)PROPYL CARBAMATES AND UREAS AND DERIVATIVES AS NOVEL NEUROKININ ANTAGONISTS ZENECA LIMITED (GB) 1997-05-29 WO disclosed